Treatment of postherpetic neuralgia: focus on pregabalin

Kimberly A CappuzzoThe Geriatric Pharmacotherapy Program, Virginia Commonwealth University, School of Pharmacy, Richmond, Virginia, USAAbstract: Postherpetic neuralgia (PHN) is a devastating, chronic pain syndrome that can develop following an outbreak of herpes zoster and becomes increasingly commo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Kimberly A Cappuzzo
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/a6c0da78a66a4247993f1b405901647a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a6c0da78a66a4247993f1b405901647a
record_format dspace
spelling oai:doaj.org-article:a6c0da78a66a4247993f1b405901647a2021-12-02T02:52:56ZTreatment of postherpetic neuralgia: focus on pregabalin1178-1998https://doaj.org/article/a6c0da78a66a4247993f1b405901647a2008-12-01T00:00:00Zhttps://www.dovepress.com/treatment-of-postherpetic-neuralgia-focus-on-pregabalin-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Kimberly A CappuzzoThe Geriatric Pharmacotherapy Program, Virginia Commonwealth University, School of Pharmacy, Richmond, Virginia, USAAbstract: Postherpetic neuralgia (PHN) is a devastating, chronic pain syndrome that can develop following an outbreak of herpes zoster and becomes increasingly common as patients age. PHN can be difficult to treat and often requires trials of multiple agents to achieve significant pain relief. Pregabalin is the newest agent to gain approval for PHN. Data suggest efficacy for relief of pain and sleep disturbance secondary to PHN in affected patients. Although there are no head-to-head comparisons, pregabalin appears comparable to gabapentin and other first-line agents for treating PHN.Keywords: pregabalin, postherpetic neuralgia, neuropathic painKimberly A CappuzzoDove Medical PressarticlePregabalinpost-herpetic neuralgiaGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 17-23 (2008)
institution DOAJ
collection DOAJ
language EN
topic Pregabalin
post-herpetic neuralgia
Geriatrics
RC952-954.6
spellingShingle Pregabalin
post-herpetic neuralgia
Geriatrics
RC952-954.6
Kimberly A Cappuzzo
Treatment of postherpetic neuralgia: focus on pregabalin
description Kimberly A CappuzzoThe Geriatric Pharmacotherapy Program, Virginia Commonwealth University, School of Pharmacy, Richmond, Virginia, USAAbstract: Postherpetic neuralgia (PHN) is a devastating, chronic pain syndrome that can develop following an outbreak of herpes zoster and becomes increasingly common as patients age. PHN can be difficult to treat and often requires trials of multiple agents to achieve significant pain relief. Pregabalin is the newest agent to gain approval for PHN. Data suggest efficacy for relief of pain and sleep disturbance secondary to PHN in affected patients. Although there are no head-to-head comparisons, pregabalin appears comparable to gabapentin and other first-line agents for treating PHN.Keywords: pregabalin, postherpetic neuralgia, neuropathic pain
format article
author Kimberly A Cappuzzo
author_facet Kimberly A Cappuzzo
author_sort Kimberly A Cappuzzo
title Treatment of postherpetic neuralgia: focus on pregabalin
title_short Treatment of postherpetic neuralgia: focus on pregabalin
title_full Treatment of postherpetic neuralgia: focus on pregabalin
title_fullStr Treatment of postherpetic neuralgia: focus on pregabalin
title_full_unstemmed Treatment of postherpetic neuralgia: focus on pregabalin
title_sort treatment of postherpetic neuralgia: focus on pregabalin
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/a6c0da78a66a4247993f1b405901647a
work_keys_str_mv AT kimberlyacappuzzo treatmentofpostherpeticneuralgiafocusonpregabalin
_version_ 1718402115895820288